Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions ; volume:10 ; number:1 ; day:10 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
Cell death discovery ; 10, Heft 1 (10.7.2024), 1-9, 12.2024
- Creator
-
Zhong, Yan
Liu, Jingfeng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-024-02077-1
- URN
-
urn:nbn:de:101:1-2409272104252.276387188382
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhong, Yan
- Liu, Jingfeng
- SpringerLink (Online service)
Other Objects (12)
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy
Kinase-targeted cancer therapies: progress, challenges and future directions
Emerging therapies for glioblastoma: current state and future directions
Advanced Acral Melanoma Therapies: Current Status and Future Directions
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy
Kinase-targeted cancer therapies: progress, challenges and future directions
Emerging therapies for glioblastoma: current state and future directions
Advanced Acral Melanoma Therapies: Current Status and Future Directions
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy
Kinase-targeted cancer therapies: progress, challenges and future directions
Emerging therapies for glioblastoma: current state and future directions